GPX4
活性氧
紫杉醇
谷胱甘肽
化学
癌症研究
抗氧化剂
脂质过氧化
癌症
癌细胞
程序性细胞死亡
谷胱甘肽过氧化物酶
细胞凋亡
细胞生物学
生物
生物化学
酶
遗传学
作者
Zhengxin Wu,Min Zhong,Yu Liu,Yubo Xiong,Zhi Gao,Jianchao Ma,Guohong Zhuang,Xuehui Hong
摘要
Ferroptosis is a regulated cell death pathway based on the deposition of lipid-based reactive oxygen species (L-ROS) in the presence of iron ions. The term was first coined in 2012 by Dixon. Decreased glutathione (GSH) synthesis and low glutathione-dependent antioxidant peroxidase 4 (GPX4) activity are the major causes of ferroptosis. Sensitivity to ferroptosis for example in tumor cells may be further enhanced by high cellular iron concentrations and/or high p53 levels. Therefore, driving ferroptosis in tumor cells could be a new way to treat tumors. Thus far, natural products have played considerable roles in antitumor research and treatment, and some drugs, such as paclitaxel, have proven beneficial in many cancer patients. According to current research, natural products can induce ferroptosis when used alone or in conjunction with other cancer therapies. This review mainly elaborates the main mechanism of ferroptosis and the regulating effects of some natural products on ferroptosis, aiming to create a new space for the research and development of novel anticancer drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI